Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
REGEnLIFE cures inflammatory brain diseases with light
Photobiomodulation: light to treat Alzheimer’s disease

Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested

Alzheimer association

Blivet G, Meunier J, Roman FJ, Touchon J.

Alzheimers Dement (N Y). 2018 Feb 2;4:54-63. doi: 10.1016/j.trci.2017.12.003. eCollection 2018.

PMID: 29955652 Free PMC article.

Share this article